PT Metro Healthcare Indonesia Tbk (IDX:CARE)
Indonesia · Delayed Price · Currency is IDR 378.00
0.00 (0.00%)
Oct 12, 2026, 4:02 PM WIB
IDX:CARE Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,568,500 | 22,610,000 | 6,284,250 | 5,320,000 | 15,827,000 | 17,123,750 | |
Market Cap Growth | 26.00% | 259.79% | 18.13% | -66.39% | -7.57% | 59.94% |
Enterprise Value | 13,162,036 | 22,955,171 | 6,695,894 | 5,509,980 | 15,567,542 | 16,795,905 |
Last Close Price | 378.00 | 680.00 | 189.00 | 160.00 | 476.00 | 515.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 2094.85 | 4565.17 | - | - | - | 2807.54 |
PS Ratio | 25.49 | 51.42 | 19.70 | 21.92 | 60.77 | 58.86 |
PB Ratio | 4.15 | 7.48 | 2.08 | 1.72 | 4.93 | 5.19 |
P/TBV Ratio | 4.16 | 7.48 | 2.08 | 1.72 | 4.95 | 5.20 |
P/OCF Ratio | 316.15 | 492.73 | - | - | - | 363.34 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 26.69 | 52.20 | 20.99 | 22.71 | 59.78 | 57.73 |
EV/EBITDA Ratio | 109.39 | 238.27 | - | - | - | 534.98 |
EV/EBIT Ratio | 141.43 | 327.86 | - | - | - | 1191.37 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.35 | 0.36 | 0.31 | 0.31 | 0.30 | 0.26 |
Debt / EBITDA Ratio | 8.82 | 11.25 | - | - | - | 26.89 |
Net Debt / Equity Ratio | 0.20 | 0.20 | 0.15 | 0.06 | 0.03 | -0.11 |
Net Debt / EBITDA Ratio | 4.92 | 6.36 | -102.54 | -13.72 | -2.75 | -11.09 |
Net Debt / FCF Ratio | -3.42 | -3.72 | -1.33 | -2.09 | -0.31 | 1.32 |
Asset Turnover | 0.12 | 0.11 | 0.08 | 0.06 | 0.06 | 0.08 |
Inventory Turnover | 45.09 | 39.07 | 39.17 | 36.03 | 33.51 | 22.54 |
Quick Ratio | 0.85 | 0.82 | 0.61 | 0.87 | 4.10 | 16.01 |
Current Ratio | 0.87 | 0.84 | 0.62 | 0.88 | 4.14 | 16.15 |
Return on Equity (ROE) | 0.21% | 0.17% | -2.61% | -3.51% | -2.88% | 0.19% |
Return on Assets (ROA) | 1.44% | 1.07% | -0.46% | -0.54% | -0.90% | 0.23% |
Return on Invested Capital (ROIC) | 1.56% | 1.26% | -0.88% | -1.09% | -1.94% | 0.47% |
Return on Capital Employed (ROCE) | 2.60% | 2.00% | -1.00% | -1.10% | -1.50% | 0.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.05% | 0.02% | -1.28% | -2.08% | -0.59% | 0.04% |
FCF Yield | -1.37% | -0.73% | -5.41% | -1.80% | -2.14% | -1.54% |
Buyback Yield / Dilution | - | - | - | - | - | -17.70% |